Cancer Establishment Admits We’re Getting Overtested and Overtreated
By John Horgan,
Scientific American
| 08. 05. 2013
I’ve complained in previous columns about excessive medical testing, which leads to unnecessary treatment and drives up health care costs. Overtesting helps explain why
health-care costs for Americans are much higher than in any other nation, whereas our health ranking is low,
roughly equivalent to that of Cubans.
The medical establishment is gradually acknowledging these hard facts, as indicated by a recent article in the
Journal of the American Medical Association: “
Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement.” The article was written by a working group formed by the American Cancer Institute last year “to develop a strategy to improve the current approach to cancer screening and prevention.”
The three authors state: “Over the past 30 years, awareness and screening have led to an emphasis on early diagnosis of cancer. Although the goals of these efforts were to reduce the rate of late-stage disease and decrease cancer mortality, secular trends and clinical trials suggest that these goals have not been met; national data demonstrate significant increases in early-stage disease, without a proportional decline...
Related Articles
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...
By Max Barnhart, Chemical & Engineering News | 06.09.2026